Cargando…
In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841121/ https://www.ncbi.nlm.nih.gov/pubmed/36642929 http://dx.doi.org/10.1002/ctm2.1105 |
| _version_ | 1784869762528968704 |
|---|---|
| author | Zhang, Meng Bian, Zichen Chen, Jia Chen, Lei Zhou, Jun Niu, Qingsong Hao, Zongyao Meng, Jialin Liang, Chaozhao |
| author_facet | Zhang, Meng Bian, Zichen Chen, Jia Chen, Lei Zhou, Jun Niu, Qingsong Hao, Zongyao Meng, Jialin Liang, Chaozhao |
| author_sort | Zhang, Meng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9841121 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98411212023-01-19 In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets Zhang, Meng Bian, Zichen Chen, Jia Chen, Lei Zhou, Jun Niu, Qingsong Hao, Zongyao Meng, Jialin Liang, Chaozhao Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-01-15 /pmc/articles/PMC9841121/ /pubmed/36642929 http://dx.doi.org/10.1002/ctm2.1105 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Zhang, Meng Bian, Zichen Chen, Jia Chen, Lei Zhou, Jun Niu, Qingsong Hao, Zongyao Meng, Jialin Liang, Chaozhao In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets |
| title | In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
|
| title_full | In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
|
| title_fullStr | In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
|
| title_full_unstemmed | In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
|
| title_short | In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
|
| title_sort | in silico validation of a new classifier, pcscg(ier), for predicting recurrence‐free survival in prostate cancer patients: evidence from multiple datasets |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841121/ https://www.ncbi.nlm.nih.gov/pubmed/36642929 http://dx.doi.org/10.1002/ctm2.1105 |
| work_keys_str_mv | AT zhangmeng insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT bianzichen insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT chenjia insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT chenlei insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT zhoujun insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT niuqingsong insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT haozongyao insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT mengjialin insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets AT liangchaozhao insilicovalidationofanewclassifierpcscgierforpredictingrecurrencefreesurvivalinprostatecancerpatientsevidencefrommultipledatasets |